{"id":"https://openalex.org/W2549823948","doi":"https://doi.org/10.1182/blood.v116.21.2143.2143","title":"Marqibo\u00ae (vincristine sulfate liposomes injection; VSLI) In the Treatment of Adult Patients with Advanced, Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL): A Combined Analysis of the VSLI-06 and RALLY Studies","display_name":"Marqibo\u00ae (vincristine sulfate liposomes injection; VSLI) In the Treatment of Adult Patients with Advanced, Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL): A Combined Analysis of the VSLI-06 and RALLY Studies","publication_year":2010,"publication_date":"2010-11-19","ids":{"openalex":"https://openalex.org/W2549823948","doi":"https://doi.org/10.1182/blood.v116.21.2143.2143","mag":"2549823948"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v116.21.2143.2143","doi":"https://doi.org/10.1182/blood.v116.21.2143.2143","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.2143.2143","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006104041","display_name":"Susan Mary O'Brien","orcid":"https://orcid.org/0000-0002-2481-7504","observed_orcids":["https://orcid.org/0000-0002-2481-7504"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan O'Brien","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038307470","display_name":"Deborah Ann Thomas","orcid":"https://orcid.org/0000-0002-2656-343X","observed_orcids":["https://orcid.org/0000-0002-2656-343X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah A Thomas","raw_affiliation_strings":["MD Anderson Cancer Center,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109430274","display_name":"Leonard T. Heffner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leonard T Heffner","raw_affiliation_strings":["Winship Cancer Institute of Emory University,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute of Emory University,","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005939966","display_name":"Wendy Stock","orcid":"https://orcid.org/0000-0002-8349-9200","observed_orcids":["https://orcid.org/0000-0002-8349-9200"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]},{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy Stock","raw_affiliation_strings":["The University of Chicago Medical Ctr.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago Medical Ctr.,","institution_ids":["https://openalex.org/I40347166","https://openalex.org/I4210087865"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113874792","display_name":"Gerald L. Messerschmidt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Gerald L. Messerschmidt","raw_affiliation_strings":["Hana Biosciences, Inc.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hana Biosciences, Inc.,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030964205","display_name":"Anne E. Hagey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Hagey","raw_affiliation_strings":["Hana Biosciences, Inc.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hana Biosciences, Inc.,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050620647","display_name":"Steven R. Deitcher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven R. Deitcher","raw_affiliation_strings":["Hana Biosciences, Inc.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hana Biosciences, Inc.,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop Kantarjian","raw_affiliation_strings":["MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5113874792"],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.9488,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.79863557,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"116","issue":"21","first_page":"2143","last_page":"2143"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-acute-lymphoblastic-leukemia","display_name":"relapsed/refractory acute lymphoblastic leukemia","score":0.968999981880188},{"id":"https://openalex.org/keywords/adult-acute-lymphoblastic-leukemia","display_name":"adult acute lymphoblastic leukemia","score":0.5799999833106995},{"id":"https://openalex.org/keywords/second-relapse","display_name":"second relapse","score":0.6959999799728394},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.7620000243186951},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5580000281333923},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.5929999947547913},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.6209999918937683},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.7889999747276306},{"id":"https://openalex.org/keywords/philadelphia-chromosome-negative","display_name":"Philadelphia chromosome-negative","score":0.6449999809265137},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.6309999823570251},{"id":"https://openalex.org/keywords/peripheral-neuropathy","display_name":"peripheral neuropathy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/liposomal-chemotherapy","display_name":"liposomal chemotherapy","score":0.5770000219345093},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.46700000762939453}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7213886976242065},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5965947508811951},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.547502338886261},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5403841137886047},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.47988641262054443},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.4563797116279602},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38047096133232117},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3538345396518707},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34232091903686523},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3355160355567932},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.13720163702964783},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.10863405466079712},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v116.21.2143.2143","doi":"https://doi.org/10.1182/blood.v116.21.2143.2143","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.2143.2143","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7300000190734863,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2588464840","https://openalex.org/W2980305338","https://openalex.org/W2596872677","https://openalex.org/W2503878702","https://openalex.org/W2571775275","https://openalex.org/W2984770023","https://openalex.org/W2531435638","https://openalex.org/W2561466620","https://openalex.org/W4200520522","https://openalex.org/W2584315631"],"abstract_inverted_index":{"Abstract":[0,1],"2143":[2],"Background:":[3],"The":[4,200,258,289,299,379,386],"outcome":[5],"of":[6,12,41,80,84,103,113,122,174,195,211,238,256,271,297,418,441,476,487,528],"adults":[7,222],"with":[8,28,94,142,182,223,247,267,307,415,465],"relapsed/refractory":[9,144,420],"ALL,":[10],"and":[11,125,128,163,193,249,327,341,349,367,397,406,447,463,493],"those":[13],"whose":[14],"disease":[15],"recurs":[16],"after":[17],"first":[18],"salvage,":[19],"in":[20,38,77,139,221,225,261,280,335,339,344,365,377,392,431,454,489,494],"particular,":[21],"is":[22,70,89,108,435],"extremely":[23],"poor.":[24],"Second":[25],"salvage":[26,51],"therapy":[27,52],"single":[29],"agents":[30],"has":[31,53],"historically":[32],"produced":[33],"a":[34,95,109,149,204,268,358,374,423,455],"complete":[35,301],"response":[36,292,302,319],"(CR)":[37,303],"only":[39],"4%":[40],"patients.":[42],"(O'Brien,":[43],"S,":[44],"et":[45],"al.":[46],"Cancer":[47],"2008;":[48],"113:3186-3191).":[49],"Third":[50],"not":[54],"been":[55,244],"studied":[56],"but":[57],"would":[58],"be":[59,62,470],"expected":[60],"to":[61,100,116,157,273,356,372,469,482,484],"even":[63],"less":[64,456],"effective.":[65],"Conventional":[66],"vincristine":[67],"sulfate":[68],"(VCR)":[69],"an":[71,525],"effective":[72],"anti-leukemia":[73,164,239],"agent,":[74],"widely":[75],"used":[76],"the":[78,324,393,429,490],"treatment":[79],"ALL":[81,224,421,500],"as":[82],"part":[83],"several":[85],"intensive":[86],"regimens.":[87],"VCR":[88,114,446],"dosed":[90],"at":[91,172,233,252],"1.4":[92],"mg/m2":[93,181,215],"2":[96],"mg":[97,189],"cap":[98,185],"due":[99],"early":[101],"onset":[102],"peripheral":[104],"neuropathy.":[105],"VSLI":[106,138,168,213,461,488],"(Marqibo)":[107],"nano-particle":[110],"encapsulated":[111],"formulation":[112],"designed":[115],"facilitate":[117],"dose":[118,184,219,255],"intensification,":[119],"improve":[120,499],"duration":[121],"drug":[123,131],"exposure,":[124],"enhance":[126],"cancer":[127],"bone":[129],"marrow":[130],"delivery.":[132],"Methods:":[133],"Two":[134],"distinct":[135],"studies":[136,263,325,394,411],"investigated":[137],"adult":[140],"patients":[141,337,353,369,414,479],"advanced,":[143],"ALL.":[145],"Study":[146,202],"VSLI-06":[147,340],"was":[148,203,264,294,315,321,333],"Phase":[150,205],"1/2,":[151],"multi-center,":[152],"36":[153],"patient,":[154],"dose-escalation":[155],"study":[156,210,384,478],"determine":[158],"safety,":[159],"maximum":[160],"tolerated":[161],"dose,":[162],"activity.":[165],"Patients":[166],"received":[167,251,444],"intravenously":[169],"(IV)":[170],"weekly":[171,217],"doses":[173],"1.5,":[175],"1.825,":[176],"2.0,":[177],"2.25":[178],"or":[179,228,311,530],"2.4":[180],"no":[183],"plus":[186],"dexamethasone":[187,467],"40":[188],"on":[190,524],"days":[191],"1\u20134":[192],"11\u201314":[194],"each":[196],"4":[197,336],"week":[198],"cycle.":[199],"RALLY":[201],"2,":[206],"multi-national,":[207],"65":[208],"patient":[209,501],"single-agent":[212],"(2.25":[214],"IV":[216],"without":[218],"cap)":[220],"second":[226],"relapse":[227],"who":[229],"had":[230,243,443],"progressed":[231],"following":[232],"least":[234,253],"two":[235,410],"prior":[236,445],"lines":[237],"therapy.":[240],"All":[241],"subjects":[242,283,442],"previously":[245],"treated":[246],"VCR,":[248],"all":[250,282],"one":[254,278],"VSLI.":[257],"median":[259],"age":[260],"both":[262],"32":[265],"years":[266],"combined":[269,290,300,424,464,477],"range":[270],"19":[272],"83":[274],"years.":[275],"Other":[276],"than":[277],"subject":[279],"VSLI-06,":[281,366],"were":[284,354,370,395,452,480],"Philadelphia":[285],"chromosome":[286],"negative.":[287],"Results:":[288],"overall":[291],"rate":[293,304,320,430],"31%":[295],"(31":[296],"101).":[298],"including":[305],"CR":[306],"incomplete":[308],"platelet":[309],"(CRp)":[310],"hematologic":[312],"(CRi)":[313],"recovery":[314],"20%":[316,425],"(20/101).":[317],"This":[318,434],"consistent":[322],"across":[323],"(19.4%":[326],"20%,":[328],"respectively).":[329],"Hematologic":[330],"improvement":[331],"(HI)":[332],"achieved":[334],"(11%)":[338],"9":[342],"(14%)":[343],"RALLY,":[345],"thus":[346],"reducing":[347],"transfusions":[348],"hospital":[350],"visits.":[351],"Five":[352],"able":[355,371,481],"receive":[357,373],"post-VSLI":[359,375],"hematopoietic":[360],"stem":[361],"cell":[362],"transplant":[363],"(HSCT)":[364],"10":[368],"HSCT":[376],"RALLY.":[378],"table":[380],"below":[381],"summarizes":[382],"key":[383],"characteristics.":[385],"most":[387],"commonly":[388],"reported":[389],"safety":[390],"events":[391],"similar":[396,416],"included":[398],"constipation,":[399],"neuropathy,":[400],"fatigue,":[401],"nausea,":[402],"pyrexia,":[403],"febrile":[404],"neutropenia,":[405],"anemia.":[407],"Conclusion:":[408],"These":[409],"totaling":[412],"101":[413],"populations":[417],"advanced":[419],"showed":[422],"CR/CRp/CRi":[426],"rate,":[427],"dwarfing":[428],"historical":[432,449],"studies.":[433],"particularly":[436],"encouraging,":[437],"given":[438],"that":[439,448],"100%":[440],"control":[450],"data":[451],"largely":[453],"heavily":[457],"pre-treated":[458],"population.":[459],"Both":[460],"alone":[462],"pulse":[466],"appear":[468],"highly":[471],"active.":[472],"In":[473],"total,":[474],"15%":[475],"\u201cbridge\u201d":[483],"HSCT.":[485],"Use":[486],"frontline":[491],"setting":[492],"combination":[495],"regimens":[496],"should":[497],"further":[498],"outcomes.":[502],"Disclosures:":[503],"Messerschmidt:":[504],"Hana":[505,510,515,519],"Biosciences,":[506,511,520],"Inc.:":[507,512,521],"Employment.":[508,513,517],"Hagey:":[509],"Deitcher:":[514],"Biosciences:":[516],"Kantarjian:":[518],"Consultancy,":[522],"Membership":[523],"entity's":[526],"Board":[527],"Directors":[529],"advisory":[531],"committees.":[532]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-11-30T00:00:00"}